Literature DB >> 8957064

Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas.

Y Imai1, H Oda, M Arai, S Shimizu, Y Nakatsuru, T Inoue, T Ishikawa.   

Abstract

Because combined hepatocellular-cholangiocellular carcinoma is rare and its biological features and pathogenesis have not been well established, we investigated alterations of the p53, K-ras and Rb-1 genes, as well as expression patterns of carcinoembryonic antigen and keratin, in seven combined hepatocellular-cholangiocarcinomas out of 557 hepatocellular carcinomas autopsied at Tokyo University during 30 years. Mutations of the p53 gene were found in two cases, at codon 244 (GGC to TGC) in the cholangiocellular carcinoma component of case 1 (mixed type, showing an intimate intermingling of both elements) and at codon 234 (TAC to AAC) in both components of case 5 (combined type, consisting of contiguous but independent masses of both elements). Mutation of the K-ras gene (codon 12, GGT to GAT) was seen only in the cholangiocellular carcinoma component of clinically apparent double cancer, case 6. Allelic alteration of the Rb-1 gene was observed in two cases, deletion of both alleles in the hepatocellular carcinoma component of case 3 (combined type) and replication error of the same pattern in both components of case 4 (mixed type). Immunohistochemical analysis showed that the hepatocellular carcinoma components of five cases (cases 2, 3, 5, 6, 7) were immunoreactive for keratin, suggesting biliary epithelial transformation. In four of the five cases (cases 3 and 5 combined, case 7 mixed and case 6 double cancer), cholangiocellular carcinoma components were also positive for keratin. These results suggest that both components of combined hepatocellular-cholangiocarcinoma have the same genetic and phenotypic character and might have arisen from the same origin in some cases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957064      PMCID: PMC5921002          DOI: 10.1111/j.1349-7006.1996.tb03110.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  22 in total

1.  Combined liver cell and bile duct carcinoma.

Authors:  R A ALLEN; J R LISA
Journal:  Am J Pathol       Date:  1949-07       Impact factor: 4.307

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Loss of somatic heterozygosity in hepatocellular carcinoma.

Authors:  G J Walker; N K Hayward; S Falvey; W G Cooksley
Journal:  Cancer Res       Date:  1991-08-15       Impact factor: 12.701

4.  Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene.

Authors:  J P McGrath; D J Capon; D H Smith; E Y Chen; P H Seeburg; D V Goeddel; A D Levinson
Journal:  Nature       Date:  1983 Aug 11-17       Impact factor: 49.962

5.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

6.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

7.  Cholangiocarcinomas in Japanese and Thai patients: difference in etiology and incidence of point mutation of the c-Ki-ras proto-oncogene.

Authors:  H Tsuda; S Satarug; V Bhudhisawasdi; T Kihana; T Sugimura; S Hirohashi
Journal:  Mol Carcinog       Date:  1992       Impact factor: 4.784

8.  Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings.

Authors:  K Aoki; K Takayasu; T Kawano; Y Muramatsu; N Moriyama; F Wakao; J Yamamoto; K Shimada; T Takayama; T Kosuge
Journal:  Hepatology       Date:  1993-11       Impact factor: 17.425

9.  Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma.

Authors:  N Nishida; Y Fukuda; H Kokuryu; T Sadamoto; G Isowa; K Honda; Y Yamaoka; M Ikenaga; H Imura; K Ishizaki
Journal:  Int J Cancer       Date:  1992-07-30       Impact factor: 7.396

10.  Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules.

Authors:  H C Hsu; T J Chiou; J Y Chen; C S Lee; P H Lee; S Y Peng
Journal:  Hepatology       Date:  1991-05       Impact factor: 17.425

View more
  12 in total

1.  Immunohistochemical analysis of p53, cyclinD1, RB1, c-fos and N-ras gene expression in hepatocellular carcinoma in Iran.

Authors:  S J Moghaddam; E N Haghighi; S Samiee; N Shahid; A R Keramati; S Dadgar; M R Zali
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

2.  Characterization of a new rat cell line established from 2'AAF-induced combined hepatocellular cholangiocellular carcinoma.

Authors:  R Gil-Benso; A Martinez-Lorente; A Pellin-Perez; S Navarro-Fos; M A Gregori-Romero; C Carda; R Callaghan; A Peydro-Olaya; A Llombart-Bosch
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-01       Impact factor: 2.416

Review 3.  Genetic profiling of intrahepatic cholangiocarcinoma.

Authors:  Jesper B Andersen; Snorri S Thorgeirsson
Journal:  Curr Opin Gastroenterol       Date:  2012-05       Impact factor: 3.287

4.  Synchronous development of HCC and CCC in the same subsegment of the liver in a patient with type C liver cirrhosis.

Authors:  Takuya Watanabe; Jun Sakata; Takashi Ishikawa; Yoshio Shirai; Takeyasu Suda; Haruka Hirono; Katsuhiko Hasegawa; Kenji Soga; Koichi Shibasaki; Yukifumi Saito; Hajime Umezu
Journal:  World J Hepatol       Date:  2009-10-31

5.  Immunohistochemical study on p53, H-rasp21, c-erbB-2 protein and PCNA expression in HCC tissues of Han and minority ethnic patients.

Authors:  Guo-Yue Lin; Zhao-Lun Chen; Cai-Mo Lu; Ying Li; Xiao-Jia Ping; Rong Huang
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

6.  A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes.

Authors:  J S Park; L Qiao; D Gilfor; M Y Yang; P B Hylemon; C Benz; G Darlington; G Firestone; P B Fisher; P Dent
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

7.  A genetic database can be utilized to identify potential biomarkers for biphenotypic hepatocellular carcinoma-cholangiocarcinoma.

Authors:  Shaffer R S Mok; Sachin Mohan; Navjot Grewal; Adam B Elfant; Thomas A Judge
Journal:  J Gastrointest Oncol       Date:  2016-08

8.  Prolonged activation of the mitogen-activated protein kinase pathway promotes DNA synthesis in primary hepatocytes from p21Cip-1/WAF1-null mice, but not in hepatocytes from p16INK4a-null mice.

Authors:  K L Auer; J S Park; P Seth; R J Coffey; G Darlington; A Abo; M McMahon; R A Depinho; P B Fisher; P Dent
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

Review 9.  Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.

Authors:  An-Qiang Wang; Yong-Chang Zheng; Juan Du; Cheng-Pei Zhu; Han-Chun Huang; Shan-Shan Wang; Liang-Cai Wu; Xue-Shuai Wan; Hao-Hai Zhang; Ruo-Yu Miao; Xin-Ting Sang; Hai-Tao Zhao
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

10.  Simultaneous presentation of hepatocellular carcinoma in identical twin brothers.

Authors:  Gokhan Demir; Sedef Belentepe; Mustafa Ozguroglu; Aykut Ferhat Celik; Nur Sayhan; Salim Tekin; Nil Molinas Mandel; Evin Buyukunal; Suheyla Serdengecti
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.